Pharma companies are taking a second look at startups in 2012. These companies are known to be a driving force in the research and development of new medications. This is currently a lucrative area, and many of these startups provide a lot of innovation in this field. These new companies are able to work in a number of ways that are not available to many of the largest firms. They often have a greater freedom to develop their products.